Clinical Trial Update: A Novel Role of Alpha Lipoic Acid in Comparison With Selenium in Mitochondrial Resuscitation and miRNA-126 Expression in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial reporting on alpha lipoic acid versus selenium for mitochondrial resuscitation and miRNA-126 expression in hemodialysis patients, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hemodialysis-related Oxidative Stress

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)
• Selenium (selenium)

Snippet

Sponsor: Ain Shams University | Conditions: Antioxidative Stress, End Stage Renal Disease on Dialysis | Phase 4 | Status: COMPLETED